200 related articles for article (PubMed ID: 37582735)
1. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.
Yue SW; Liu HL; Su HF; Luo C; Liang HF; Zhang BX; Zhang W
Mol Cancer; 2023 Aug; 22(1):137. PubMed ID: 37582735
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
3. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
Zhang Y; Zhan L; Li J; Jiang X; Yin L
Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
[TBL] [Abstract][Full Text] [Related]
4. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
[TBL] [Abstract][Full Text] [Related]
5. The potential role of m6A modifications on immune cells and immunotherapy.
Gan L; Zhao Y; Fu Y; Chen Q
Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
[TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.
Kumari S; Kumar S; Muthuswamy S
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1621-1633. PubMed ID: 35796777
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
8. [Research Progress of m6A Methylation Modification in Hematological Tumors--Review].
Li F; Yang FF; Xu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1607-1611. PubMed ID: 36208274
[TBL] [Abstract][Full Text] [Related]
9. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
[TBL] [Abstract][Full Text] [Related]
10. Paeonol represses A549 cell glycolytic reprogramming and proliferation by decreasing m6A modification of Acyl-CoA dehydrogenase.
Zhang L; Wu L; Zhu X; Mei J; Chen Y
Chin J Physiol; 2023; 66(4):248-256. PubMed ID: 37635484
[TBL] [Abstract][Full Text] [Related]
11. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
Qiao H; Liu L; Chen J; Shang B; Wang L
Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of RNA modification N6-methyladenosine in human cancer.
Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
[TBL] [Abstract][Full Text] [Related]
13. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
[TBL] [Abstract][Full Text] [Related]
14. The Role of RNA m
Li Y; Huang H; Wu S; Zhou Y; Huang T; Jiang J
Curr Gene Ther; 2023; 23(1):51-59. PubMed ID: 36043793
[TBL] [Abstract][Full Text] [Related]
15. The role of N6-methyladenosine mRNA in the tumor microenvironment.
Li M; Zha X; Wang S
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188522. PubMed ID: 33545295
[TBL] [Abstract][Full Text] [Related]
16. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
Chen F; Xie X; Chao M; Cao H; Wang L
Front Immunol; 2022; 13():917153. PubMed ID: 35711459
[TBL] [Abstract][Full Text] [Related]
17. RNA m6A modifications regulate crosstalk between tumor metabolism and immunity.
Gu J; Cao H; Chen X; Zhang XD; Thorne RF; Liu X
Wiley Interdiscip Rev RNA; 2024; 15(1):e1829. PubMed ID: 38114887
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis.
Zhao W; Li J; Ma Q; Cai J; Li A; Wu W; Lv Y; Cai M
J Cell Physiol; 2022 Jul; 237(7):2729-2739. PubMed ID: 35342948
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.
Chen J; Fang X; Zhong P; Song Z; Hu X
RNA Biol; 2019 Aug; 16(8):991-1000. PubMed ID: 31107151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
